The birth and postnatal development of purinergic signalling

被引:107
作者
Burnstock, G. [1 ]
Fredholm, B. B. [2 ]
North, R. A. [3 ]
Verkhratsky, A. [3 ]
机构
[1] Royal Free & Univ Coll Med Sch, Auton Neurosci Ctr, London NW3 2PF, England
[2] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
[3] Univ Manchester, Fac Life Sci, Manchester, Lancs, England
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
adenosine; ATP; co-transmission; history; purinergic signalling; purinoceptors; ADENOSINE A(1) RECEPTORS; CENTRAL-NERVOUS-SYSTEM; INTRACELLULAR CALCIUM-CONCENTRATION; DEPOLARIZATION-INDUCED RELEASE; FAST SYNAPTIC-TRANSMISSION; NITRIC-OXIDE SYNTHASE; CYCLIC-AMP PRODUCTION; PAROTID ACINAR-CELLS; ISOLATED PORTAL-VEIN; DORSAL-HORN NEURONS;
D O I
10.1111/j.1748-1716.2010.02114.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The purinergic signalling system is one of the most ancient and arguably the most widespread intercellular signalling system in living tissues. In this review we present a detailed account of the early developments and current status of purinergic signalling. We summarize the current knowledge on purinoceptors, their distribution and role in signal transduction in various tissues in physiological and pathophysiological conditions.
引用
收藏
页码:93 / 147
页数:55
相关论文
共 984 条
  • [1] International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
    Abbracchio, Maria P.
    Burnstock, Geoffrey
    Boeynaems, Jean-Marie
    Barnard, Eric A.
    Boyer, Jose L.
    Kennedy, Charles
    Knight, Gillian E.
    Fumagalli, Marta
    Gachet, Christian
    Jacobson, Kenneth A.
    Weisman, Gary A.
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (03) : 281 - 341
  • [2] Purinergic signalling in the nervous system: an overview
    Abbracchio, Maria P.
    Burnstock, Geoffrey
    Verkhratsky, Alexei
    Zimmermann, Herbert
    [J]. TRENDS IN NEUROSCIENCES, 2009, 32 (01) : 19 - 29
  • [3] PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS
    ABBRACCHIO, MP
    BURNSTOCK, G
    [J]. PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) : 445 - 475
  • [4] Purinergic signalling: Pathophysiological roles
    Abbracchio, MP
    Burnstock, G
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (02) : 113 - 145
  • [5] Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A(3) receptor - Pathophysiological significance and therapeutic implications for neurodegenerative disorders
    Abbracchio, MP
    Ceruti, S
    Brambilla, R
    Franceschi, C
    Malorni, W
    Jacobson, KA
    vonLubitz, DKJE
    Cattabeni, F
    [J]. NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE, 1997, 825 : 11 - 22
  • [6] Abbracchio MP, 1998, DRUG DEVELOP RES, V45, P379, DOI 10.1002/(sici)1098-2299(199811/12)45:3/4<379::aid-ddr38>3.0.co
  • [7] 2-y
  • [8] PURINOCEPTOR NOMENCLATURE - A STATUS-REPORT
    ABBRACCHIO, MP
    CATTABENI, F
    FREDHOLM, BB
    WILLIAMS, M
    [J]. DRUG DEVELOPMENT RESEARCH, 1993, 28 (03) : 207 - 213
  • [9] CONTROL OF PROSTAGLANDIN BIOSYNTHESIS IN RAT-BRAIN HOMOGENATES BY ADENINE-NUCLEOTIDES
    ABDULLA, YH
    MCFARLANE, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1972, 21 (21) : 2841 - +
  • [10] ABDULLA YH, 1970, LANCET, V1, P378